Clinical trial

Non - Opioid Treatments (Single Administration) for Pain During the Early Postpartum Period After Vaginal Delivery

Name
0368-20-TLV
Description
The investigators will examine the effectiveness of non-opioid analgesia (Paracetamol versus Ibuprofen) in the early postpartum period
Trial arms
Trial start
2020-11-28
Estimated PCD
2022-07-01
Trial end
2023-07-06
Status
Completed
Treatment
Paracetamol 1000 mg
Women participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg
Arms:
Paracetamol group
Ibuprofen 400 mg
Women participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia, by envelope contains paracetamol 1000 mg or ibuprofen 400 mg
Arms:
Ibuprofen group
Size
107
Primary endpoint
Pain relief after treatment with Paracetamol or Ibuprofen
6 hours after intervention
Eligibility criteria
Inclusion Criteria: * Women between the ages of 18-50, who gave birth in a vaginal birth Exclusion Criteria: * Sensitivity to Paracetamol or Ibuprofen * After cesarean section * Received analgesia prior to study recruitment * Perineal tears grade 3 \\ 4 * Women with chronic pain, rheumatic disease, fibromyalgia, or trauma * Women with a diagnosis or medication for anxiety or depression * Dropout for women whose newborns needed respiratory support with intubation, cooling, prolonged hospitalization in NICU exceeding one week
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': '* Women participating in the study will receive postpartum analgesia immediately while reporting pain requiring analgesia (NRS \\<3)\n* Pain Reliefs will be given in a double-blind mechanism, in closed envelopes\n* The envelopes will contain Paracetamol 1000 mg or Ibuprofen 400 mg\n* Women participating in the study will answer a questionnaire to characterize the pain while taking the pain relief (time 0), an hour later (time 1), 4 and 6 hours later (time 4 and time 6)', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'The primary investigator will be the only one to have the information about envelopes contain', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER']}}, 'enrollmentInfo': {'count': 107, 'type': 'ACTUAL'}}
Updated at
2024-02-20

1 organization

2 products

1 indication

Indication
Pain
Product
Ibuprofen